Improving access to CML diagnostic testing and monitoring globally

Improving access to diagnostics is one of the most challenging issues to address on a large scale. Through small grants and partnerships with CML centres of excellence the ERSAP Diagnosis and Testing Program plans to enable centres in emerging regions to increase their local capacity to conduct diagnostic and long term monitoring of their CML patients. We hope that, for the first time in many cases, physicians will be able to locally confirm the diagnosis of CML patients, leading to better treatment and long term care. This has the potential to dramatically alter the lives of the patients and their families, in some cases whole communities.